Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
8.28
-0.38 (-4.39%)
At close: Mar 28, 2025, 4:00 PM
8.38
+0.10 (1.26%)
After-hours: Mar 28, 2025, 5:12 PM EDT
Sage Therapeutics Revenue
In the year 2024, Sage Therapeutics had annual revenue of $41.24M, down -52.30%. Sage Therapeutics had revenue of $12.82M in the quarter ending December 31, 2024, a decrease of -83.56%.
Revenue (ttm)
$41.24M
Revenue Growth
-52.30%
P/S Ratio
12.20
Revenue / Employee
$116,836
Employees
353
Market Cap
509.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.24M | -45.21M | -52.30% |
Dec 31, 2023 | 86.46M | 78.77M | 1,024.84% |
Dec 31, 2022 | 7.69M | 1.38M | 21.85% |
Dec 31, 2021 | 6.31M | -1.11B | -99.43% |
Dec 31, 2020 | 1.11B | 1.11B | 16,123.06% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSAGE News
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - Accesswire
- 3 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Investors to Learn More About the Investigation - Accesswire
- 5 days ago - Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Investors to Connect - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Stockholders to Inquire about Securities Investigation - Accesswire
- 15 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation - Accesswire
- 19 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Investors to Reach Out - Accesswire